Terminated PHASE1 INTERVENTIONAL 4-arm NCT03054207

Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients (IMPACT/R)

Sponsor: Jules Desmeules

Conditions Hiv

Interventions Clopidogrel 300Mg Tablet Prasugrel 60Mg

Updated 6 times since 2017 Last updated: Sep 8, 2017 Started: Jun 30, 2015 Primary completion: Apr 30, 2017 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

difficulty to recruit

Other Hiv trials with similar outcome

NCT03163277 · Phase PHASE4 · Jun 2020

Browse all Hiv trials

This PHASE1 trial investigates Hiv and is currently terminated or withdrawn. Jules Desmeules leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Oct 2017 — Jun 2018 [monthly]

Terminated PHASE1

Status: Recruiting → Terminated

▶ Show 1 earlier version

Feb 2017 — Oct 2017 [monthly]

Recruiting PHASE1

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jules Desmeules

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Geneva, Switzerland